Recent Transactions

19-Dec-19
$13.5 million
U.S.A., Japan flags
Target: 

Nitta Casings and Nitta Casings Canada

Spain flag
Acquiror: 
Viscofan

Advised Viscofan (BME:VIS), the #1 producer of artificial casings for the meat industry worldwide (>30% market share), on the acquisition of Nitta Casings and Nitta Casings Canada (“NCI” and “NCCI”) one of the leading brands in the production of collagen casings in North America, from Nitta Gelatin (TSE:4977)  

19-Nov-19
$NA
United States flag
Target: 

New Belgium Brewing

Japan, Australia flags
Acquiror: 
Lion / Kirin

Advised Lion, one of Australasia’s leading beverage companies and a wholly owned subsidiary of Japanese conglomerate Kirin Holdings, on the acquisition of New Belgium Brewing, a leading US independent craft brewery

18-Sep-19
$NA
United States flag
Target: 

CME Group Inc.

Malaysia flag
Acquiror: 
Bursa Malaysia Berhad

Advised CME Group, Inc., the operator of a leading global derivatives marketplace, on the structured sale of its 25% equity stake in Bursa Malaysia Derivatives Berhad to Bursa Malaysia Berhad

23-Aug-19
$NA
United Kingdom flag
Target: 

TT International

Japan flag
Acquiror: 
Sumitomo Mitsui Financial Group, Inc.

Advised TT International, a leading independent asset management firm focused on managing high alpha, high conviction active management strategies for institutional investors, on its sale to Sumitomo Mitsui Financial Group, Inc.

26-Apr-19
$200 million
Japan, Australia flags
Target: 

Lion's Specialty Cheese division

Canada flag
Acquiror: 
Saputo Inc.

Advised Lion, an Australian subsidiary of Kirin and one of Australasia’s leading food and beverage companies, on the sale of its Specialty Cheese division to Saputo, one of the top ten dairy processors in the world  

22-Mar-19
$NA
Australia flag
Target: 

Four Pillars Gin

Japan, Australia flags
Acquiror: 
Lion Beer Australia

Advised Lion, an Australian subsidiary of Kirin, on its acquisition of a strategic stake in Four Pillars Gin, Australia’s leading craft gin distillery

18-Jan-19
$NA
Brazil flag
Target: 

TPP Camaçari Muricy II & TPP Pecem II

China flag
Acquiror: 
CCETC

Advised MDC, a Brazilian investment fund, on the sale of Thermoelectric Power Plants Camaçari Muricy II & Pecem II to Jiangsu Communication Clean Energy Technology (CCETC)

25-Dec-18
$184 million
Japan flag
Target: 

Hitachi's Automotive Lithium-Ion Battery Business

Japan flag
Acquiror: 
INCJ, Maxell Holdings

Advised Hitachi, a leading global industrial conglomerate, on the sale of its LiB business including Hitachi Vehicle Energy

03-Dec-18
$4.0 billion
United Kingdom flag
Target: 

Assets owned by GlaxoSmithKline plc

Acquiror: 
Unilever plc / Hindustan Unilever Limited

Advised GlaxoSmithKline plc, the UK listed international pharmaceutical and consumer healthcare company, on the divestment of Horlicks and other consumer healthcare nutrition brands to Unilever plc, and on the merger of GSK Consumer Healthcare Limited with Hindustan Unilever Limited

01-Nov-18
$NA
Japan flag
Target: 

Long-term lithium hydroxide offtake agreement with Mitsui & Co.

Australia flag
Acquiror: 
Kidman Resources Limited

Advised Kidman Resources Limited, an ASX-listed hard rock lithium mining company with a 50% interest in the West Australian Mt. Holland lithium project, on a lithium hydroxide offtake agreement with Mitsui & Co., a leading global marketing and trading conglomerate based in Japan. The agreement is for an initial term of two years, plus two 2-year term extension options

12-Sep-18
$NA
United States flag
Target: 

Uniseal, Inc.

Korea flag
Acquiror: 
LG Chem Ltd.

Advised LG Chem, a global diversified chemicals manufacturer based in South Korea, on the acquisition of Uniseal, a US-based supplier of sealants and adhesives to leading automotive manufacturers

21-Aug-18
$171 million
Japan flag
Target: 

Nihon Nohyaku Co., Ltd.

Japan flag
Acquiror: 
ADEKA Corporation

Advised ADEKA Corporation, a global chemical manufacturer, on the acquisition of 51% stake of Nihon Nohyaku via the combination of the Tender Offer and Capital Injection

09-Aug-18
$1.2 billion
Target: 

Martabe gold and silver mine

Acquiror: 
PT United Tractors Tbk

Advised EMR Capital, a specialist resources private equity manager, on the sale of the Martabe gold and silver mine to United Tractors

08-Aug-18
$538 million
Australia flag
Target: 

Suncorp Group Limited’s Australian Life Insurance Business

Japan flag
Acquiror: 
TAL

Advised TAL, Australia’s largest and leading insurance business that is 100% owned by Dai-ichi Life of Japan, on the acquisition of Suncorp Group Limited’s Australian Life Insurance business

25-Jul-18
$145 million
United States flag
Target: 

Park Electrochemical (Electronics Business)

Japan flag
Acquiror: 
AGC Inc.

Advised Park Electrochemical, a leading high-performance electronics materials manufacturer, on the sale of its Electronics Business to AGC Inc.

28-Jun-18
$146 million
United States flag
Target: 

35% of Sabine Oil & Gas’ interest in oil and gas properties in East Texas

Japan flag
Acquiror: 
Osaka Gas

Advised Osaka Gas, a Japanese utility, on the acquisition of 35% of Sabine Oil & Gas’s interest in oil and gas properties located primarily in Harrison and Panola Counties, Texas

07-May-18
$7.1 billion
Israel flag
Target: 

Frutarom

United States flag
Acquiror: 
International Flavors and Fragrances

Advised IFF, a leading innovator of specialty ingredients, on its acquisition of Frutarom, creating a global leader in Taste, Scent and Nutrition

27-Mar-18
$1.6 billion
Japan flag
Target: 

Yakult

France flag
Acquiror: 
Danone

Advised Danone, a leading global food & beverage company, on renewing its strategic partnership with Yakult, a global leader in probiotic beverages, as well as the sale of part of its stake in Yakult

26-Mar-18
$NA
Australia flag
Target: 

Remedy Kombucha

Japan, Australia flags
Acquiror: 
Lion Dairy & Drinks

Advised Lion, an Australian subsidiary of Kirin, on its acquisition of a strategic stake in Remedy Kombucha, Australia’s leading producer and distributer of kombucha beverages

30-Nov-17
$NA
Germany flag
Target: 

MorphoSys AG

China flag
Acquiror: 
I-Mab

Advised MorphoSys AG, a German biopharmaceutical company, on a regional licensing agreement covering Greater China and comprising its investigational anti-CD38 antibody MOR202 targeting multiple myeloma, with I-Mab

14-Jul-17
$775 million
Australia flag
Target: 

Programmed Maintenance Services Limited

Japan flag
Acquiror: 
PERSOL HOLDINGS CO LTD.

Advised PERSOL HOLDINGS, one of Japan’s largest HR service companies, on its acquisition of ASX-listed Programmed Maintenance Services, a leading Australian and New Zealand based provider of staffing and maintenance services

03-Apr-17
$205 million
Australia flag
Target: 

Inenco Group Pty Ltd

United States flag
Acquiror: 
Genuine Parts Company

Advised Inenco Group Pty Ltd, one of Australasia’s leading industrial distributors, on the partial sale to Genuine Parts Company, a global distributor of automotive and industrial products

22-Feb-17
$533 million
Japan, Australia flags
Target: 

Lion’s stake in Warrnambool Cheese and Butter Factory Company

Canada flag
Acquiror: 
Saputo Inc.

Advised Lion (an Australian subsidiary of Kirin), on the sale of its strategic stake in Warrnambool Cheese and Butter Factory to Canadian-based Saputo, under its all cash takeover offer

14-Nov-16
$NA
Japan, Australia flags
Target: 

Lion’s Australian Premium Wine Business – Fine Wine Partners

Australia flag
Acquiror: 
Accolade Wines

Advised Lion, a leading Australasian food and beverage company wholly owned by Japanese conglomerate Kirin, on the sale of its Australian wine business Fine Wine Partners to Accolade Wines, a portfolio company of CHAMP Private Equity

05-Oct-16
$775 million
U.K., Ireland flags
Target: 

Assets and operations of Actavis Generics in the UK and Ireland from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Accord Healthcare Ltd.

Advised Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on its sale of assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited) for £603m (c.$775m) 

Pages

show all